News

Protalix BioTherapeutics Issues Letter to Stockholders

by

CARMIEL, Israel, May 30, 2023 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced the following letter from its President and Chief Executive Officer, Dror Bashan, to its stockholders and … Read more

JK Tech to showcase their latest Healthcare Technology Solutions at Healthcare Providers Transformation Assembly organized by The Millennium Alliance

by

NEW YORK, May 30, 2023 /PRNewswire/ — JK Tech, a global provider of next-generation Digital and Business Consulting Services has announced its participation in the upcoming Healthcare Providers Transformation Assembly organized by The Millennium Alliance. The assembly is scheduled in Chicago on June 20-21, 2023. Healthcare Providers Transformation Assembly will be an opportunity for healthcare … Read more

[Latest Report] Intraocular Lens Market is estimated to be US$ 7.9 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032)

by

COVINA, Calif., May 30, 2023 /PRNewswire/ — According to Prophecy Market Insights “Intraocular Lens Market Flourishes with 7.2% CAGR, Envisaged to Cross US$ 7.9 billion Mark by 2032.” What is the Overview of Intraocular Lens Market? Intraocular Lenses (IOLs) are artificial, permanent lenses which can replace eye’s natural lens for restoring near & distant vision. Firstly, … Read more

PainTEQ Announces Decision from Patent Trial and Appeal Board in IPR Proceeding

by

TAMPA, Fla., May 30, 2023 /PRNewswire/ — PainTEQ, a fast-growing medical innovation company, announced that on May 24, 2023, the Patent Trial and Appeal Board (PTAB) issued a final written decision in an inter partes review (IPR) proceeding directed to U.S. Patent No. 10,426,539 (539 Patent), handing PainTEQ a decisive victory.  The patent is owned … Read more

The Foundation Assar Gabrielsson Prize recipients 2023 appointed

by

GOTHENBURG, Sweden, May 30, 2023 /PRNewswire/ — The Assar Gabrielsson Foundation has appointed Malin Lindén as the winner in the basic science research category and Aron Onerup as the winner in the clinical research category. The prize recipients are rewarded with SEK 100,000 each as extra research grants, administered by the Sahlgrenska Academy at the … Read more

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand USA – English USA – English

by

MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ — Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Philogen S.p.A (BIT: PHIL) today announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ (Daromun) in … Read more

Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-Class ADC Pipeline

by

Strengthening of strategic option license agreement to cover additional novel ADC targets COPENHAGEN, Denmark, May 30, 2023 /PRNewswire/ — Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical need, announced the expansion of its current collaboration with Duality Biologics (“Duality”), … Read more

Medivir to present at the ABGSC Life Science Summit

by

STOCKHOLM, May 30, 2023 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the ABGSC Life Science Summit today May 30, 2023. CEO Jens Lindberg will present the company and its plan for … Read more

Tidetron se distingue au Future Food Asia 2023, et remporte le prix de la startup de biotechnologie agroalimentaire à la croissance la plus rapide en Chine USA – Français USA – English APAC – English USA – español

by

SINGAPOUR, 30 mai 2023 /PRNewswire/ — La 7e édition du Future Food Asia (FFA) s’est terminée en mai, avec un triomphe retentissant pour Tidetron Bioworks Technology Co., Ltd. La performance exceptionnelle de l’entreprise dans l’industrie de la biotechnologie agroalimentaire lui a valu le titre convoité de la « Startup de biotechnologie agroalimentaire à la croissance la … Read more